Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -109.77 | 262.00 | — | — | — | 309.72 | 224.17 | — | 438.30 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -15.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 11.47 | 8.50 | 8.83 | 6.95 | 6.41 | 3.41 | 2.18 | 4.31 | 4.01 | 3.16 | 1.65 | 2.11 | 1.71 | 1.30 | 2.56 | 2.74 | 2.92 | 3.40 | 2.50 | 2.68 | 3.08 |
| — | +149.5% | +304.6% | +61.5% | +59.9% | +7.8% | +32.2% | +104.2% | +134.1% | +142.7% | -35.6% | -23.2% | -41.3% | -61.7% | +2.7% | +2.5% | -5.2% | -35.1% | -62.2% | -59.7% | -44.4% | |
| P/B Ratio | 20.35 | 5.20 | 9.61 | 6.98 | 11.92 | 6.78 | 4.41 | 7.94 | 7.62 | 6.19 | 3.31 | 3.75 | 3.07 | 2.20 | 4.03 | 4.13 | 4.18 | 4.96 | 3.38 | 3.20 | 3.45 |
| — | -23.3% | +118.2% | -12.0% | +56.4% | +9.5% | +33.2% | +111.9% | +148.0% | +181.4% | -17.9% | -9.2% | -26.5% | -55.7% | +19.1% | +29.1% | +21.1% | -12.7% | -54.8% | -53.6% | -41.0% | |
| P/FCF | 187.70 | 42.58 | 1024.85 | — | 214.40 | 150.76 | 17.65 | — | 25.00 | 55.67 | 26.98 | — | — | — | — | — | — | — | — | — | — |
| — | -71.8% | +5705.9% | — | +757.7% | +170.8% | -34.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 214.21 | — | — | — | 57.50 | 38.44 | 1002.96 | 52.98 | 100.88 | 56.49 | — | — | — | — | — | — | — | — | — | — |
| — | +272.5% | — | — | — | -43.0% | -31.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 243.01 | — | — | — | 19.76 | 52.52 | — | 92.54 | 4753.04 | 349.22 | — | — | — | — | — | — | — | — | — | — |
| — | +1129.9% | — | — | — | -99.6% | -85.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.3% | 74.8% | 72.7% | 75.2% | 74.1% | 76.6% | 74.2% | 71.9% | 76.1% | 74.9% | 73.8% | 78.8% | 78.7% | 76.8% | 77.7% | 81.7% | 83.0% | 83.3% | 81.8% | 82.1% | 82.8% |
| — | -2.3% | -2.0% | +4.5% | -2.5% | +2.2% | +0.5% | -8.7% | -3.3% | -2.5% | -5.1% | -3.5% | -5.2% | -7.8% | -4.9% | -0.5% | +0.3% | +0.1% | +3.7% | -1.5% | -0.5% | |
| Operating Margin | -3.5% | 1.3% | -3.1% | -4.6% | -16.3% | 3.2% | 3.0% | -3.4% | 4.1% | -0.6% | -0.9% | -11.0% | -7.4% | -9.8% | -18.1% | -20.0% | -15.5% | -13.1% | -23.0% | -36.5% | -17.0% |
| — | -60.4% | -204.8% | -34.7% | -499.6% | +589.9% | +430.3% | +69.0% | +154.9% | +93.3% | +95.1% | +45.0% | +52.0% | +25.8% | +21.3% | +45.2% | +8.6% | +38.7% | -8.0% | -82.2% | -2.6% | |
| Net Margin | -7.0% | 3.1% | -2.2% | -31.9% | -22.0% | 1.2% | 1.0% | -7.9% | 0.9% | -3.8% | -4.0% | -16.0% | -9.1% | -9.9% | -17.5% | -19.3% | -15.0% | -11.7% | -22.5% | -37.0% | -16.8% |
| — | +161.2% | -312.8% | -303.6% | -2511.3% | +130.9% | +125.5% | +50.8% | +110.0% | +61.4% | +77.0% | +16.9% | +39.4% | +15.2% | +22.3% | +47.9% | +10.7% | +48.9% | +4.5% | -72.5% | +9.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -13.5% | 0.6% | -0.6% | -10.5% | -10.5% | 0.6% | 0.5% | -3.7% | 0.4% | -1.9% | -2.0% | -7.0% | -4.0% | -4.2% | -6.8% | -7.1% | -5.3% | -4.3% | -7.5% | -10.6% | -4.6% |
| — | +2.1% | -213.7% | -186.1% | -2480.7% | +131.9% | +126.2% | +47.9% | +111.0% | +54.6% | +70.3% | +1.4% | +24.8% | +1.3% | +9.1% | +32.8% | -15.3% | +30.3% | -13.7% | -93.4% | +5.5% | |
| ROA | -7.4% | 0.5% | -0.5% | -7.7% | -6.0% | 0.3% | 0.3% | -1.9% | 0.2% | -1.0% | -1.0% | -3.5% | -2.0% | -2.1% | -3.5% | -3.7% | -2.8% | -2.2% | -3.9% | -5.7% | -2.5% |
| — | +62.6% | -276.9% | -299.6% | -2741.2% | +134.4% | +128.2% | +44.6% | +111.4% | +53.9% | +70.7% | +5.8% | +28.2% | +4.0% | +11.0% | +35.0% | -9.5% | +35.1% | -1.4% | -69.2% | +16.8% | |
| ROIC | -3.8% | 0.4% | -0.9% | -1.2% | -4.5% | 0.9% | 0.8% | -0.8% | 1.0% | -0.2% | -0.2% | -2.4% | -1.8% | -2.2% | -3.5% | -3.6% | -2.7% | -2.3% | -3.8% | -5.6% | -2.8% |
| — | -56.7% | -209.7% | -49.2% | -538.2% | +664.0% | +471.1% | +66.0% | +156.2% | +92.9% | +93.9% | +32.7% | +33.1% | +3.9% | +6.0% | +35.0% | +3.0% | +36.9% | +5.7% | -57.3% | +14.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.52 | 0.04 | 0.08 | 0.08 | 0.52 | 0.56 | 0.61 | 0.65 | 0.66 | 0.69 | 0.75 | 0.74 | 0.72 | 0.69 | 0.69 | 0.69 | 0.67 | 0.67 | 0.67 | 0.65 | 0.60 |
| — | -93.0% | -87.1% | -87.0% | -20.6% | -18.8% | -18.7% | -12.5% | -8.7% | +0.5% | +7.8% | +7.9% | +8.5% | +3.3% | +4.1% | +5.1% | +11.4% | +11.1% | +15.8% | +44.3% | +35.1% | |
| Debt / EBITDA | 196.60 | 7.35 | — | — | — | 18.10 | 19.53 | 309.70 | 17.47 | 41.76 | 43.80 | — | — | — | — | — | — | — | — | — | — |
| — | -59.4% | — | — | — | -56.7% | -55.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.11 | 12.02 | 6.60 | 7.10 | 5.11 | 4.09 | 4.14 | 4.28 | 3.24 | 3.74 | 3.51 | 3.43 | 2.89 | 3.28 | 3.60 | 4.18 | 4.13 | 4.35 | 4.52 | 4.90 | 5.23 |
| — | +194.1% | +59.3% | +65.9% | +57.7% | +9.1% | +17.8% | +24.8% | +12.1% | +14.1% | -2.4% | -17.9% | -30.0% | -24.6% | -20.4% | -14.8% | -21.1% | -24.7% | -31.0% | -19.2% | -17.8% | |
| Quick Ratio | 3.31 | 10.67 | 5.04 | 5.33 | 3.31 | 2.64 | 2.67 | 2.65 | 2.16 | 2.47 | 2.32 | 2.23 | 2.14 | 2.42 | 2.71 | 3.24 | 3.33 | 3.54 | 3.71 | 4.14 | 4.54 |
| — | +304.6% | +88.9% | +101.3% | +53.6% | +6.8% | +15.2% | +19.0% | +1.0% | +2.2% | -14.6% | -31.4% | -35.9% | -31.7% | -26.9% | -21.8% | -26.6% | -30.8% | -37.5% | -24.2% | -21.9% | |
| Interest Coverage | -1.04 | 2335.00 | -2156.00 | -27.22 | -6.66 | 1.07 | 1.29 | -0.70 | 1.25 | 0.02 | 0.12 | -1.85 | -1.11 | -3.94 | -44.00 | -441.13 | — | -69.79 | -30.08 | -31.42 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AXGN stock.
AxoGen, Inc.'s current P/E is -109.8x. The average P/E over the last 1 quarters is 262.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
AxoGen, Inc.'s current operating margin is -3.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking AxoGen, Inc.'s business trajectory between earnings reports.